- Home
- HWKN vs SLNO Comparison
HWKN vs SLNO Comparison
Compare HWKN & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWKN
- SLNO
- Stock Information
- Founded
- HWKN 1938
- SLNO 1999
- Country
- HWKN United States
- SLNO United States
- Employees
- HWKN N/A
- SLNO N/A
- Industry
- HWKN Specialty Chemicals
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HWKN Consumer Discretionary
- SLNO Health Care
- Exchange
- HWKN Nasdaq
- SLNO Nasdaq
- Market Cap
- HWKN 3.5B
- SLNO 3.8B
- IPO Year
- HWKN N/A
- SLNO 2014
- Fundamental
- Price
- HWKN $167.14
- SLNO $69.77
- Analyst Decision
- HWKN Buy
- SLNO Strong Buy
- Analyst Count
- HWKN 2
- SLNO 10
- Target Price
- HWKN $200.00
- SLNO $112.50
- AVG Volume (30 Days)
- HWKN 158.7K
- SLNO 1.6M
- Earning Date
- HWKN 10-29-2025
- SLNO 11-05-2025
- Dividend Yield
- HWKN 0.43%
- SLNO N/A
- EPS Growth
- HWKN 5.20
- SLNO N/A
- EPS
- HWKN 4.05
- SLNO N/A
- Revenue
- HWKN $1,011,824,000.00
- SLNO $32,656,999.00
- Revenue This Year
- HWKN $15.35
- SLNO N/A
- Revenue Next Year
- HWKN $6.76
- SLNO $175.39
- P/E Ratio
- HWKN $41.32
- SLNO N/A
- Revenue Growth
- HWKN 9.51
- SLNO N/A
- 52 Week Low
- HWKN $98.30
- SLNO $41.50
- 52 Week High
- HWKN $185.50
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- HWKN 48.96
- SLNO 42.02
- Support Level
- HWKN $163.22
- SLNO $65.85
- Resistance Level
- HWKN $173.80
- SLNO $70.12
- Average True Range (ATR)
- HWKN 4.46
- SLNO 2.55
- MACD
- HWKN -1.25
- SLNO 0.27
- Stochastic Oscillator
- HWKN 30.41
- SLNO 63.97
About HWKN Hawkins Inc.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.